ESSIG STUART 4

What Happened
Stuart Essig, a director of IDEXX Laboratories (IDXX), received two equity awards on 2026-05-12: 525 stock options (derivative award) and 234 restricted stock units (RSUs). Both awards are reported at $0.00 (no cash paid) in the Form 4; these are grants/awards rather than open‑market purchases or sales.

Key Details

• Transaction date: 2026-05-12. Filing date (Form 4): 2026-05-14 (timely filing).
• Awards: 525 option units (grant, footnote F1) and 234 RSUs (grant, footnote F2); reported price $0.00 for each grant.
• Vesting: Both awards vest in one installment on the one‑year anniversary of the grant or on the date of the 2027 annual meeting of shareholders, whichever is earlier (per F1/F2).
• Shares owned after transaction: Not specified in the filing.
• Transaction type: A = grant/award (derivative for the option grant, contingent stock units for RSUs). No exercise or sale occurred.

Context

• The 525 units are an option grant (right to buy shares subject to vesting); the 234 units are RSUs (contingent rights to receive shares on vesting). No immediate cash changed hands and no shares were sold.
• These grants are typical of director compensation and do not, by themselves, indicate buying or selling sentiment.